Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/9812
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBaldwin, Ian Cen
dc.contributor.authorBellomo, Rinaldoen
dc.contributor.authorKoch, Billen
dc.date.accessioned2015-05-15T23:03:47Z-
dc.date.available2015-05-15T23:03:47Z-
dc.date.issued2004-09-24en
dc.identifier.citationIntensive Care Medicine 2004; 30(11): 2074-9en
dc.identifier.govdoc15448889en
dc.identifier.otherPUBMEDen
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/9812en
dc.description.abstractReductions in blood flow rate may occur undetected during peristaltic pumping of blood through continuous renal replacement therapy circuits. We investigated whether undetected reductions in blood flow rate occur during continuous veno-venous haemofiltration, and whether they are correlated with filter life.Twelve patients receiving continuous veno-venous haemofiltration in the intensive care unit of a tertiary hospital.Extracorporeal circuit blood flow during haemofiltration was continuously monitored utilizing a miniature ultrasound Doppler device. Otherwise undetected blood flow reductions were identified at severity levels of between 20% and 100% less than the set diastolic flow rate (83 ml/min). Information on anticoagulation status was simultaneously obtained. The frequency and severity of blood flow reductions were recorded, and the correlation with filter life was determined.The duration of filter life ranged from 1.5 to 53 h, with a mean functional life of 19.62+/-16.32 h. There were 314 episodes of blood flow reduction during the 525 h of monitoring (0.59 episodes/h). There was a significant inverse relationship between the number of medium-level blood flow reductions and filter life. This correlation was much stronger than that between APTT and filter life.Undetected blood flow reductions occur during continuous veno-venous haemofiltration. Such reductions are frequent, and when sufficiently severe appear to be correlated with filter life more strongly than the blood coagulation variables typically used to monitor adequacy of anticoagulation and promote filter longevity.en
dc.language.isoenen
dc.subject.otherAdulten
dc.subject.otherAgeden
dc.subject.otherBlood Flow Velocityen
dc.subject.otherEquipment Failure Analysisen
dc.subject.otherFemaleen
dc.subject.otherFiltration.instrumentationen
dc.subject.otherHemofiltration.instrumentationen
dc.subject.otherHumansen
dc.subject.otherMaleen
dc.subject.otherMiddle Ageden
dc.subject.otherRenal Dialysis.instrumentationen
dc.subject.otherStatistics, Nonparametricen
dc.titleBlood flow reductions during continuous renal replacement therapy and circuit life.en
dc.typeJournal Articleen
dc.identifier.journaltitleIntensive Care Medicineen
dc.identifier.affiliationDepartment of Intensive Care, Austin Health, Heidelberg, Victoria, Australiaen
dc.identifier.doi10.1007/s00134-004-2440-0en
dc.description.pages2074-9en
dc.relation.urlhttps://pubmed.ncbi.nlm.nih.gov/15448889en
dc.type.austinJournal Articleen
local.name.researcherBaldwin, Ian C
item.fulltextWith Fulltext-
item.openairetypeJournal Article-
item.cerifentitytypePublications-
item.grantfulltextopen-
item.languageiso639-1en-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
crisitem.author.deptIntensive Care-
crisitem.author.deptIntensive Care-
crisitem.author.deptData Analytics Research and Evaluation (DARE) Centre-
Appears in Collections:Journal articles
Files in This Item:
File SizeFormat 
15448889.pdf43.77 kBAdobe PDFView/Open
Show simple item record

Page view(s)

44
checked on Feb 16, 2025

Download(s)

96
checked on Feb 16, 2025

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.